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Abstract
Mitochondrial DNA (mtDNA) sequence variants segregate in mutation and tissue-specific manners, but the mechanisms
remain unknown. The segregation pattern of pathogenic mtDNA mutations is a major determinant of the onset and severity
of disease. Using a heteroplasmic mouse model, we demonstrate that Gimap3, an outer mitochondrial membrane GTPase, is
a critical regulator of this process in leukocytes. Gimap3 is important for T cell development and survival, suggesting that
leukocyte survival may be a key factor in the genetic regulation of mtDNA sequence variants and in modulating human
mitochondrial diseases.
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Introduction
Mammalian mitochondrial DNA (mtDNA) is a maternally
inherited high copy genome. Copy number ranges from 10
2 to 10
5
depending upon the cell type, and typically, there is a single
haplotype or sequence variant in a cell (homoplasmy) [1–3].
Germline or somatic cell mutations in mtDNA lead to the co-
occurrence of two or more sequence variants in a cell, a state
known as heteroplasmy. In the absence of selection, the
segregation of mtDNA sequence variants can be modeled as a
random walk using two parameters: copy number and rate of
turnover [4]. However, in some cases there is preferential selection
for one mtDNA sequence variant over another, which depends
upon the variant, tissue, and nuclear background.
Most human pathogenic mtDNA mutations are heteroplasmic,
and typically oxidative phosphorylation function is impaired when
the proportion of mutant mtDNA exceeds a critical threshold in
the cell [5,6], leading to a wide spectrum of clinical disorders,
generally affecting tissues with a high aerobic demand [1].
Transmission of most mutations through the female germline is
stochastic [7]; however, in somatic tissues, mtDNA mutations can
have skewed segregation patterns depending upon the mutation,
tissue, and pedigree [6–14]. For instance, there is negative
selection for the A3243G mutation in tRNA
leu usually associated
with MELAS (Mitochondrial Encephalomyopathy, Lactic Acido-
sis, Stroke-like episodes) in peripheral blood, but not in other
tissues [15,16]. However, this segregation pattern is not observed
for other mitochondrial tRNA mutations, such as A8344G
associated with MERRF (Myoclonic Epilepsy with Ragged-red
fibers) [13,17]. Thus, while both tRNA mutations impair
mitochondrial translation, genetically these mutations are treated
differently in the same cell types. To investigate the molecular
basis for tissue-specific mtDNA segregation, we have used a
heteroplasmic mouse model segregating two neutral mtDNA
haplotypes derived from two old inbred mouse strains, BALB and
NZB [18]. Transmission of these haplotypes through the female
germline is neutral [18]; however, in post-natal life, the BALB
mtDNA haplotype accumulates in hematopoietic tissues, while in
the kidney and liver there is selection for the NZB haplotype [19].
In every other tissue investigated there is no preference for either
mtDNA haplotype. The mechanisms for this mtDNA selection
between tissues are apparently completely different [20,21].
Previously, we demonstrated that nuclear-encoded genes regulate
this selection process and mapped the quantitative trait loci (QTL)
involved [22]. Further, we showed that selection for the BALB
mtDNA haplotype in hematopoietic tissues can be completely
eliminated in certain nuclear backgrounds [21]. In this study, we
show that Gimap3 is a critical gene for regulating mtDNA
segregation hematopoietic tissues in this model.
Results
Selection for the BALB mtDNA haplotype in hematopoietic
tissues with age is rapid, proportional to the starting heteroplasmy
level, and can be modeled as an exponential function [21]. The
phenotype is robust, being found in a number of Mus musculus
domesticus strains (DBA, 129Sv, NZB, C3H, C57BL/6J). In
contrast, on the CAST/Ei mouse nuclear background, selection
for the BALB mtDNA haplotype in hematopoietic tissues is
completely abolished [21], suggesting that a combination of
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genetic basis underlying this binary mtDNA segregation pheno-
type in hematopoietic tissues, we outcrossed heteroplasmic BALB/
c females with CAST/Ei males to generate an F2 intercross
(BALB/c X CAST/Ei). Mice were grouped into two phenotypes,
based on either the absence or presence of mtDNA selection in the
spleen (Figure 1). Mice were classified as having no mtDNA
selection, if the % NZB mtDNA in hematopoietic tissues was
similar to that of neutral tissues ie. those in which only random
segregation is observed. All other mice were classified as positive
for mtDNA selection, regardless of the rate of selection. In F2
mice, we found age-dependent regulation of this mtDNA
segregation phenotype. At three months of age, approximately
40% of the F2 mice showed no mtDNA selection in the spleen,
while at 12 months of age only 6% of F2 mice maintained the
same phenotype. There was no difference between males and
females.
Clearly the genetic regulation of this binary mtDNA segregation
phenotype is complex, yet we reasoned that at 12 months of age,
two fully penetrant recessive loci could account for the frequency
of such a phenotype. We performed a genome-wide linkage scan
on 12 month old F2 mice (n=168) using 680 SNPs to map loci
regulating the absence of mtDNA segregation. We identified an 11
Mb interval on chromosome 6 (37.4–48.99 Mb) significantly
linked to the loss of mtDNA selection (LOD 4.6, genome-wide
p=0.007 with 10, 000 permutations, Figure 2). No other loci
across the genome reached statistically significant levels after the
permutation analysis. However, we did detect two suggestive loci
(p,0.63) [23], one on chromosome 11 (p=0.310) and another on
chromosome 13 (p=0.557). We had previously mapped this same
Author Summary
Mitochondria are essential cellular organelles, which
contain their own small circular genome in mammals.
The mitochondrial genome is maternally inherited and
encodes proteins critical for aerobic energy production.
Mutations in mitochondrial DNA can lead to disruptions in
aerobic energy production, which manifest as a wide
spectrum of human clinical disorders. These mutations can
segregate in mitotic and post-mitotic tissues, so that the
proportion of the mutant genome can change with age,
thereby affecting the clinical onset and severity of disease.
The mechanisms regulating mtDNA segregation in mam-
mals are not understood. We have used a mouse model of
mtDNA segregation to elucidate the molecular basis of this
process. Here, we demonstrate that the gene, Gimap3, can
regulate mtDNA segregation in mouse white blood cells.
This is the first gene identified to regulate mtDNA
segregation in mammals, which is also an important factor
in cell survival. Future work on this protein will provide
critical insight into the pathways that regulate mitochon-
drial DNA in white blood cells, an important factor in the
pathogenesis of human mitochondrial DNA mutations.
Figure 1. MtDNA segregation in hematopoietic tissues of 12-month-old heteroplasmic F2 (BALB/c X CAST/Ei) mice. A representative
profile of mtDNA heteroplasmy levels in hematopoietic (spleen, peripheral blood, and bone marrow) and neutral tissues (heart, brain and skeletal
muscle) from four 12-month-old F2 (BALB/c X CAST/Ei) mice illustrates the mtDNA segregation phenotypes. Mice were classified as having no (-)
mtDNA selection if the % NZB mtDNA in hematopoietic tissues was similar to neutral tissues or having (+) mtDNA selection. Data is presented from
mice with high (.60%) or moderate (35%) levels of NZB heteroplasmy in their neutral tissues.
doi:10.1371/journal.pgen.1001161.g001
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mtDNA selection in the spleen at 12 months of age [22]. Together,
these results confirms that chromosome 6 contains a gene(s) critical
for the regulation of mtDNA segregation in hematopoietic tissues.
To identify candidate genes within this 11 Mb interval, we
searched for those annotated with a putative role in mitochondrial
biology (GO:0005739 - mitochondrion) and found six matching
this criterion (Table 1). Evaluating candidate genes for a tissue-
specific role in mitochondrial biology is a difficult process, because
most mitochondrial genes tend to be ubiquitously expressed. Gstk1,
Ndufb2 and Mrps33 are ubiquitously expressed, and the latter two
would presumably affect oxidative phosphorylation function.
However, we and others have shown that there is no difference
in respiratory chain function between NZB and BALB mtDNA
haplotypes [20,24]. Little is known of the putative kinase Adck2.
In contrast, Gimap3 and Gimap5, paralogues with 84% identity at
the amino acid level (Figure 3A), have immune-related functions
and make particularly attractive candidate genes because the
mtDNA segregation phenotype occurs only in hematopoietic
tissues.
We sequenced the full-length cDNA of Gimap3 and Gimap5 from
total RNA extracted from BALB/c and CAST/Ei spleens.
Gimap5 contained two missense changes (Val to Ile and Arg to
Ser) between BALB and CAST variants (Figure 3B). Neither of
these amino acid variants are evolutionarily conserved in other
Gimap family members [25]. However, for Gimap3 we found
differential exon splicing with the CAST/Ei variant missing one of
five exons. Gimap3 consists of five exons with two in frame AUG
start sites in exons 3 and 4. Exon 4 also contains a stop codon
upstream of the second AUG start site, so when all five exons are
spliced together, the second start is used for translation of the
mature protein (Figure 4). In the CAST/Ei Gimap3 mRNA, exon 4
is missing so translation starts from the first AUG (Figure 4),
thereby altering the reading frame to produce a mature protein
with an extra 58 amino acids at the N-terminus (Figure 4). We
sequenced across exon 4 in genomic DNA from BALB/c and
CAST/Ei and discovered a G to A transition in the splice acceptor
site of exon 4 in CAST/Ei that prevents splicing of this exon into
the mRNA (Figure 4). Since this mtDNA segregation phenotype is
conserved among a variety of Mus musculus domesticus strains [22],
we sequenced across exon 4 in four of these strains and found that
the genomic sequence was identical to that of BALB/c (Figure 4).
This altered mRNA splicing for the CAST/Ei allele changes
considerably the Gimap3 protein sequence in the soluble domain
of the protein, but does not affect the C-terminal transmembrane
domain (Figure 4), which anchors and localizes it to the outer
mitochondrial membrane [26].
MtDNA segregation in hematopoietic tissues is age-dependent,
but it is unclear what role Gimap3 has in younger mice. To test
whether there was an association of the CAST/Ei allele with the
loss of mtDNA selection in the spleen, we genotyped the Gimap3
locus in three month old F2 mice (n=145). Indeed, we observed a
significant enrichment for the CAST/Ei allele in mice with no
mtDNA selection and loss of the CAST/Ei allele in mice with
mtDNA selection (Figure 5). This data suggests Gimap3 plays an
important role in mtDNA segregation in hematopoietic tissues
independent of age and made Gimap3 an attractive candidate gene.
To definitively test for a role of Gimap3 in regulating mtDNA
segregation, we generated transgenic mice overexpressing the
Cast/Ei Gimap3 cDNA driven off the ubiquitous ROSA26
promoter (Figure 6). The transgene was expressed ubiquitously,
as expected from this promoter, and at a higher level than the
endogenous Gimap3 in the spleen (Figure 6). Transgenic males
Figure 2. A chromosome 6 locus significantly affects mtDNA segregation in hematopoietic tissues. Genome-wide linkage analysis from
168 F2 (BALB/c X CAST/Ei) mice searching for loci regulating the loss of mtDNA selection. Only the chromosome 6 locus was significantly linked to
this phenotype (LOD 4.6, genome-wide p=0.007 with 10,000 permutations).
doi:10.1371/journal.pgen.1001161.g002
Table 1. Chromosome 6 genes located between 37–49 Mb
with a role in mitochondrial biology (GO:0005739).
Gene Position (Mb) Function
Adck2 39.52 kinase of unknown function
Ndufb2 39.54 Complex I subunit
Mrps33 39.75 mitochondrial ribosomal protein
Gstk1 42.19 protein disulfide oxidoreductase
Gimap5 48.66 immune related GTPase
Gimap3 48.71 immune related GTPase
doi:10.1371/journal.pgen.1001161.t001
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three months of age. Our previous QTL mapping results
demonstrated that the Smdq-3 locus on chromosome 6 has an
additive genetic effect, so our expectation was the CAST/Ei Gimap
3 allele would slow the rate of mtDNA segregation in the spleen.
Consistent with our expectation, overexpression of the CAST/Ei
Gimap3 in the spleen significantly slowed the rate of mtDNA
segregation compared to littermate controls and our heteroplasmic
mouse model on the BALB/c nuclear background (Figure 6).
These results confirm Gimap3 is an important regulator of
hematopoietic mtDNA segregation.
Our results further support the hypothesis that the pathways
regulating mtDNA segregation are indeed tissue or cell-specific. In
our heteroplasmic mouse model, mtDNA selection for the NZB
haplotype in the liver and kidney is regulated by different genes and
with different kinetics [20,22]. Ectopic expression of the CAST
Gimap3transgenehad noeffectonNZBmtDNAselectionintheliver
or kidney (Figure 7), nor had any effect on mtDNA segregation in
tissues which are neutral for selection in our mouse model, such as
the brain, heart, lung, and skeletal muscle. Consistent with this
finding, retroviral overexpression of the CAST Gimap3 in
heteroplasmic murine embryonic fibroblasts had no effect on
heteroplasmy levels (Figure 7). These results imply that a cell-specific
context or pathway is also required to alter mtDNA segregation.
Mitochondrial genome copy number regulation has been
proposed to influence the segregation of mtDNA haplotypes and
human mtDNA mutations. To test whether changes in mtDNA
copy number regulate mtDNA segregation in hematopoietic
tissues, we measured the copy number in the spleen of F2 mice
and found no difference between mice with either absence or
presence of mtDNA selection (Figure 8). These data demonstrate
that copy number regulation per se is not a major determinant for
this particular mtDNA segregation phenotype, and that Gimap3
expression has no role in regulating mtDNA copy number.
Figure 3. Gimap3 and Gimap5 protein sequences. A. ClustalW alignment of BALB Gimap3 and Gimap5 protein sequences. B. ClustalW
alignment of BALB and CAST Gimap5.
doi:10.1371/journal.pgen.1001161.g003
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AUG start codon is present in both exon 3 and exon 4. In exon 4, upstream of AUG start codon is a stop codon. In the BALB/c allele all 5 exons are
spliced together, so translation of the mature protein initiates at the second AUG start codon, with a predicted size of 34 kDa. In the CAST/Ei allele, a
G-A transition in the splice acceptor site of exon 4 prevents its splicing into the mature mRNA, so exon 4 is missing and translation initiates from the
first AUG start codon, predicting a protein of 41 kDa. B. Alignment of the Gimap3 exon 4 and flanking intronic sequence from 5 Mus musculus
domesticus strains, all of which are indistinguishable in the phenotype for mtDNA segregation compared to the Mus musculus castaneus CAST/Ei
strain. C. ClustalW alignment of CAST and BALB Gimap3 protein sequences.
doi:10.1371/journal.pgen.1001161.g004
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In this study, we identify the first nuclear-encoded gene that
influences mtDNA segregation in mammals. Gimap3 is an outer
mitochondrial membrane GTPase, which we show genetically can
regulate the rate of mtDNA segregation inhematopoietic tissues. We
also demonstrate that segregation of mtDNA haplotypes in mouse
hematopoietic tissues is a complex genetic trait regulated with age
butindependentofmtDNAcopynumber.VariationinGimap3alone
does not account for the entire segregation phenotype for the
following reasons. At three months of age, some mice homozygous
for the CAST allele still exhibit mtDNA selection, the phenotype is
age-dependent, and in our transgenic mice, overexpression of the
CAST Gimap3 had a quantitative effect on the rate of mtDNA
segregation. These observations suggest other genes, such as the two
suggestive loci detected on chromosome 11 and 13 in the linkage
analysis are involved in the regulation of mtDNA segregation.
MtDNA selection in hematopoietic tissues of both humans and
mice can be modeled as an exponential function, however, the rates
are significantly different, up to 70 times faster in our mouse model
than in humans [17]. In humans carrying the A3243G MELAS
mutation, there is depletion of mtDNA independent of hetero-
plasmy level and age, which might be a secondary effect of the
mutation and a driver for selection of wild type mtDNA [16].
However, the mechanism that leads to a decreased copy number
and drives selection for the wild type mtDNA remains unknown.
Rajasimha et al. [17] have postulated that selection against the
A3243G MELAS mutation likely occurs in the stem cell population
of rapidly dividing cells. Data from our mouse model do not support
this mechanism of segregation, even though in our BALB/c
heteroplasmic mouse model, selection for mtDNA occurs in
leukocytes from both lymphoid and myeloid lineages [21]. In
rapidly dividing colonic crypts there is no selection for mtDNA
haplotypes [18], and, in our F2 (BALB/c X CAST/Ei) cross the
frequency of mice that have lostmtDNA selection changes with age.
Gimap3 is a member of the conserved Gimap (GTPase of
immunity-associated protein) gene cluster found only in vertebrates,
with an orthologue in angiosperm plants [25–28]. Both Gimap3
and Gimap5 (a paralogue of Gimap3) contain a G1 to G5 switch
GTPase, two coiled-coil motifs, and a hydrophobic conserved box
[25]. In humans, only GIMAP5 is a functional gene producing two
splice variants with predicted molecular masses of 34.8 and
39.5 kDa, while GIMAP3 appears to be a pseudogene [25]. Very
little is known about protein function, and in particular the role of
the GTPase domain and the conserved box remain an enigma.
These two proteins are critical for T cell development and cell
survival, and shown to interact with anti-apoptotic Bcl-2 family
members, but the mechanisms are not understood [27]. Gimap5
wasoriginallyidentifiedasthefactorresponsibleforthesevereT cell
lymphopenia in the diabetes prone BioBreeding rat [29], although
in mice loss of Gimap5 function produces a broader and more
severe phenotype, which includes a leukocyte developmental defect,
liver dysfunction, and lethality (median age of death around 14–15
weeks) [30]. The CAST/Ei variant of Gimap3 only differs at the N-
terminus, leaving intact all of the known functional domains of the
protein, including the C-terminus required for membrane insertion
and localization. How these extra 58 amino acids in the CAST/Ei
Gimap3 variant affect protein function requires further character-
ization of Gimap3 in leukocytes.
How can an outer mitochondrial membrane protein regulate
mtDNA segregation in hematopoietic tissues? Selection for
mtDNA haplotypes can only be directed at two levels, either at
the DNA sequence itself or at the proteins encoded within it.
Analysis of Gimap3 protein sequence does not support a direct
physical interaction with mtDNA, because the protein does not
appear to span both mitochondrial membranes into the matrix
space in order to facilitate such an interaction. One possibility is
that Gimap3 acts as a node or switch on the outer membrane for a
retrograde signaling cascade involving mitochondrial peptide
export, a process that occurs across eukaryotes [31–34]. Bacteria
use peptide export-import as a control circuit to regulate processes,
such as nutrient uptake and sporulation [35]. Further work on
Gimap3 will establish its function within mtDNA segregation and
whether peptide export or cell survival are involved.
Methods
Ethics Statement
These studies were approved by the McGill University Animal
Care Committee and The Regional State Administrative Agency
of Southern Finland (ESAVI).
Mice and Breeding
To produce mice for the genome scan, female BALB/c mice
h e t e r o p l a s m i cf o rt h eB A L Ba n dN Z Bm t D N Ah a p l o t y p e sw e r e
outcrossed to male CAST/Ei mice to generate an F1, which were
then intercrossed to obtain F2 progeny. Transgenic mice were made
by cloning the CAST/Ei cDNA of Gimap3 into the EcoRI site of
pBroad3 (Invivogen), which was then microinjected into fertilized
FVB embryos. Founders were screened for the transgene, germline
transmission, and autosomal inheritance. Transgenic mice were
crossed to BALB/c, and the resulting F1 males crossed to
heteroplasmic BALB/c femalesto generate heteroplasmic littermates.
Phenotyping
Tissues were collected from mice at 3 and 12 months of age and
DNA extracted by conventional methods. Heteroplasmy levels
Figure 5. Enrichment of the CAST/Ei Gimap3 allele in three-
month-old F2 mice with no mtDNA selection. Three-month-old F2
(BALB/c X CAST/Ei) mice (n=145) were classified into two groups,
presence (+) (n=88, 0.61) or absence (-) (n=57, 0.39) of mtDNA
selection, and then genotyped for their Gimap3 alleles. Distributions
were compared to the expected Mendelian ratios by Chi-square analysis
(p=0.00033).
doi:10.1371/journal.pgen.1001161.g005
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phenotype in hematopoietic tissues done according to Battersby
et al. [21]. Only animals with an initial level of NZB heteroplasmy
above 20% were included in the analysis. Relative fitness values
for NZB mtDNA in the kidney and liver were calculated as
previously described [22].
MtDNA Quantitation
Relative levels of mtDNA to nuclear DNA were determined
using SYBR Green (Kapa Biosystems) on a Bio-Rad CFX96
thermal cycler with primers for mtDNA (forward 59- GAG-
CATCTTATCCACGCTTCC, reverse 59-GGTGGTACTCCC-
GCTGTAAA) and the single copy nuclear-encoded gene beta-2
microglobulin (forward 5-TGTCAGATATGTCCTTCAGCA-
AGG, reverse 5-TGCTTAACTCTGCAGGCGTATG). Samples
and standards were run in triplicate and used only after comparing
the post-run amplification efficiencies.
Genotyping
The Illumina Medium Density Linkage Panel was used for SNP
genotyping of mouse heart genomic DNA. From a total of 1449
markers on the panel, 680 SNPs were informative between BALB/
Figure 6. Transgenic expression of CAST/Ei Gimap3 cDNA in heteroplasmic mice slows the rate of splenic mtDNA segregation. A.
CAST/Ei Gimap3 transgene expression across a number of mouse tissues (B-brain; L-lung; H-heart; S-spleen) driven off the ROSA26 promoter.
Endogenous Gimap3 expression from BALB/c or CAST/Ei spleen was loaded as a control. Equal amounts of total RNA were amplified by RT-PCR under
the same conditions in each tissue. Beta-actin was used as a control. B. CAST/Ei Gimap3 transgene expression in three-month-old mice significantly
slows down the mean rate of mtDNA segregation in the spleen compared to littermate controls and the BALB/c heteroplasmic mouse model
(ANOVA, p=0.0011). Data are presented as a scatter plot with means indicated (bar). Transgene negative (n=16) and positive (n=17); BALB/c
(n=23).
doi:10.1371/journal.pgen.1001161.g006
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DNA by PCR using primers (forward 59- ACGTGCACAGACC-
CATTTCT, reverse 59- GTGCTGGAGGGAAGTTTGTC) and
then digested Hpy188III and separated on agarose gels. Mice were
screened for the presence of the transgene using a PCR assay that
amplified the Gimap3 CAST/Ei cDNA and the BALB/c gene
(forward 59-CATACCGTCACACCATCTGC, reverse 59-
CTTTTACCGCAGCCAGATTT), which amplifies a 320 bp
fragment from the cDNA and a 1700 bp fragment from the
gene.
RNA Analysis
All tissues sampled were frozen in liquid nitrogen and stored at
280uC. Total RNA was extracted with Trizol (Invitrogen) then
treated with DNaseI to eliminate potential DNA contamination.
Gimap3 cDNAs were amplified from BALB/c and CAST/Ei
spleens by RT-PCR (Qiagen) with primers (forward 59-
TCCTGCCTGAGAGACTGTTG, reverse 59- TGTGAGTGA-
TCCCAATCCAC). Transgene and endogenous Gimap3 expres-
sion was measured by RT-PCR using equal amounts of total RNA
with primers for Gimap3 (forward 59- TGGACTTCCCATTGG-
TAAACA, reverse 59-ACCCCAAAGACCTCCTTCAC) and
beta-actin (forward 59 -TCACCCACACTGTGCCCATCTAC,
reverse 59 -GAGTACTTGCGCTCAGGAGGAGC).
Retroviral Constructs
Full-length cDNAs were cloned into a Gateway (Invitrogen)
converted pBABE-puro retroviral expression vector and transfect-
ed into the Phoenix amphotropic packaging line to transiently
Figure 7. Ectopic expression of Gimap3 has no effect on mtDNA segregation. A. Relative fitness of NZB mtDNA in the liver and kidney of F2
transgenic littermates positive or negative for the CAST/Ei Gimap3 cDNA. Data are presented as means 6 SD (transgene negative, n=16; and
positive, n=17). B. Cultured heteroplasmic murine embryonic fibroblasts were transduced with BALB Gimap3 or CAST Gimap3 containing an N-
terminal HA tag in pBABE, or with empty vector (pBABE). Cells were grown continuously in culture for 1 month. The change in NZB heteroplasmy in
the bulk culture was determined comparing the level after 1 month of culture to the initial level before retroviral transduction.
doi:10.1371/journal.pgen.1001161.g007
Figure 8. MtDNA copy number regulation in the spleen has no
effect on mtDNA segregation. MtDNA copy number relative to
nuclear DNA was measured in the spleen of three month F2 (BALB/c X
CAST/Ei) mice with or without mtDNA selection. Data are presented as
means 6 SD (+ mtDNA selection, n=32; - mtDNA selection, n=13).
doi:10.1371/journal.pgen.1001161.g008
Gimap3 and Mitochondrial DNA Segregation
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heteroplasmic murine embryonic fibroblasts.
Statistical Analysis
Linkage analysis was carried out by regression at the markers
under a logistic regression model and an allele dosage mode of
inheritance. The genome wide corrected p-values were based on a
10,000 permutation sample. Allele distributions of Gimap3 in three
month old F2 mice were analyzed by Chi-Square analysis
comparing to an expected Mendelian distribution. The effect of
the CAST/Ei transgene on mtDNA segregation was analyzed in
datasets first for normality, followed by ANOVA and posthoc
testing.
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